Triple-positive breast cancer cannot be said to be the best cure, but it is relatively easier to be cured, and the specific therapeutic effect needs to be analyzed according to the clinical staging of the breast cancer patient and the patient’s status, etc. Triple-positive breast cancer is also called triple-positive breast cancer.
Triple-positive breast cancer is also called triple-positive breast cancer, in which the expression of estrogen receptor, progesterone receptor and HER2 are all positive. Clinically, there are many treatment options for triple-positive breast cancer, and the overall treatment effect and cure rate are good, as long as the treatment is active and standardized, the condition can be effectively controlled.
Surgery, chemotherapy, radiotherapy, endocrine therapy and anti-HER2 targeted therapy are some of the treatment options for triple Yang breast cancer. Early stage patients are generally recommended to undergo surgical resection. For patients who cannot undergo surgery, comprehensive treatment such as target therapy and immunotherapy can be carried out.